Clinical Trials on Short Cervix in Denmark

Total 32 results

GlyPharma Therapeutics
VectivBio AG

Completed

Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency

SBS - Short Bowel Syndrome

Denmark
University of Copenhagen

Completed

Effect of Synbiotic on Composition of Human Gut Microbiota and Production of Short and Branched-chain Fatty Acids

Synbiotics | Healthy Humans | Composition of Gut Microbiota | Short and Branched-chain Fatty Acids

Denmark
University of Aarhus

Unknown

Colposcopy and Dynamic Spectral Imaging (DSI)

Cervical Cancer | Cervix Cancer | Cervical Dysplasia | Cervical Lesion | Cervical Neoplasm | Cervical Disease

Denmark
University of Aarhus

Completed

See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia

Cervical Dysplasia | Cervical Lesion | Cervix Disease

Denmark
University of Aarhus

Unknown

Follow-up of Abnormal and Inadequate Smear-test Results

Carcinoma in Situ of Uterine Cervix

Denmark
Zealand Pharma
Larix A/S

Completed

A Phase 2 Trial Testing ZP1848 in Patients With SBS (glepaglutide)

Short Bowel Syndrome

Denmark
Zealand Pharma

Completed

The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome (EASE SBS 4)

Short Bowel Syndrome

Denmark
GlyPharma Therapeutics
VectivBio AG

Completed

Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support

Short Bowel Syndrome

Denmark
University of Aarhus
Randers Regional Hospital

Recruiting

Screening Triage and Risk Stratification (I-share)

Cervix Cancer | Postmenopausal Women | HPV Testing

Denmark
Odense University Hospital

Terminated

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Rectal Cancer | Ulcerative Colitis | Short Bowel Syndrome

Denmark
Glostrup University Hospital, Copenhagen

Unknown

Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome

Short Bowel Syndrome

Denmark
University of Aarhus
University of Copenhagen

Completed

Osmolality of Oral Supplements and Ileostomy Output

Ileostomy - Stoma | Short Bowel Syndrome | Nutritional Deficiency | Sodium Depletion

Denmark
Christian Hvas

Completed

Absorption of Peptides, Fluid, and Electrolytes in Patients With an Ileostomy (ABSOLYT)

Short Bowel Syndrome | Nutritional Deficiency | Ileostomy; Functional Disturbance | Absorption; Disorder, Protein

Denmark
University of Southern Denmark
University College Lillebælt

Completed

The Svendborg-project (CHAMPS-DK)

Physical Activity | Risk Factor, Cardiovascular | Obesity, Childhood | Motor Activity | Sports Injury

Denmark
Rigshospitalet, Denmark

Completed

18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Cervix Cancer

Denmark
University of Copenhagen
Lund University; Herlev Hospital

Completed

Energy Availability in Female Athletes

Female Athlete Triad

Denmark, Sweden
University College of Northern Denmark

Recruiting

Safe Return to Play After Concussion

Sports Injury | Concussion, Brain

Denmark
Universitätsklinikum Hamburg-Eppendorf
Aarhus University Hospital; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaborators

Terminated

Comparison of Peroral Endoscopic Myotomy (POEM) With Laparoscopic Heller Myotomy (LHM) for Treatment of Achalasia (POEM3)

Comparison of Short- Term Success Rates of POEM With LHM | Comparison of Long-term Success Rates of POEM With LHM

Denmark, Germany, Netherlands, Switzerland
University of Aarhus

Completed

Three Birds With One Stone

Colorectal Neoplasms | Colorectal Cancer | Colorectal Carcinoma | Uterine Cervical Cancer | Uterine Cervical Neoplasm | Mass Screening | Early Detection of Cancer | Uterine Cervix Cancer

Denmark
Zealand Pharma

Enrolling by invitation

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial (EASE SBS 3)

Short Bowel Syndrome

Germany, United States, Belgium, Denmark, France, United Kingdom, Netherlands, Poland
Hanmi Pharmaceutical Company Limited

Recruiting

Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects

Short Bowel Syndrome

Belgium, Korea, Republic of, United States, Germany, Denmark, France, Poland
Herlev and Gentofte Hospital
University of Copenhagen

Completed

High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs

Malignant Melanoma | Cancer of Cervix | Cancer of the Prostate | Cancer, Ovarian | Lymphedema of Leg | Cancer, Endometrial

Denmark
Shire
Nycomed Germany GmbH

Completed

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

Short Bowel Syndrome

Spain, United States, Canada, France, Denmark, Poland, Germany, Italy, United Kingdom
Shire

Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Short Bowel Syndrome

United States, Denmark, France, Canada, Belgium, Netherlands, Poland, United Kingdom
Zealand Pharma

Completed

Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) (EASE SBS 1)

Short Bowel Syndrome

United States, Denmark, Belgium, Germany, France, United Kingdom, Canada, Netherlands, Poland
Shire

Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

Short Bowel Syndrome

United States, France, Germany, Canada, Netherlands, Poland, Denmark, Belgium, United Kingdom
Zealand Pharma

Recruiting

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS (EASE SBS 2)

Short Bowel Syndrome

United States, France, Belgium, Denmark, United Kingdom, Germany, Canada, Italy, Netherlands, Poland
Shire
Nycomed

Completed

Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects (STEPS)

Short Bowel Syndrome

United States, Spain, France, Canada, Netherlands, Denmark, Germany, Italy, Poland, United Kingdom
VectivBio AG

Active, not recruiting

Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. (STARS extend)

Short Bowel Syndrome

United States, Belgium, United Kingdom, Korea, Republic of, Japan, Taiwan, Germany, France, Czechia, Hungary, Spain, Italy, Poland, Argentina, Denmark, Israel, Norway, Sweden
VectivBio AG

Completed

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF (STARS)

Short Bowel Syndrome

United States, France, United Kingdom, Israel, Korea, Republic of, Germany, Japan, Taiwan, Sweden, Belgium, Spain, Czechia, Hungary, Norway, Italy, Argentina, Denmark, Poland
Seagen Inc.
Genmab

Completed

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Bladder Cancer | Cervix Cancer | Ovary Cancer | Esophagus Cancer | Endometrium Cancer | Prostate Cancer (CRPC) | Lung Cancer (NSCLC)

United States, United Kingdom, Belgium, Hungary, Denmark
Seagen Inc.
Genmab

Completed

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Bladder Cancer | Cervix Cancer | Ovary Cancer | Esophagus Cancer | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Endometrium Cancer | Prostate Cancer (CRPC) | Lung Cancer(NSCLC)

United States, Belgium, United Kingdom, Denmark, Sweden

Clinical Trials on Short Cervix in Denmark

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations